Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Journal of Virology Vol. 82; no. 21; pp. 10502 - 10509 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.11.2008
American Society for Microbiology (ASM) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | H5N1 influenza A viruses are exacting a growing human toll, with more than 240 fatal cases to date. In the event of an influenza pandemic caused by these viruses, embryonated chicken eggs, which are the approved substrate for human inactivated-vaccine production, will likely be in short supply because chickens will be killed by these viruses or culled to limit the worldwide spread of the infection. The Madin-Darby canine kidney (MDCK) cell line is a promising alternative candidate substrate because it supports efficient growth of influenza viruses compared to other cell lines. Here, we addressed the molecular determinants for growth of an H5N1 vaccine seed virus in MDCK cells, revealing the critical responsibility of the Tyr residue at position 360 of PB2, the considerable requirement for functional balance between hemagglutinin (HA) and neuraminidase (NA), and the partial responsibility of the Glu residue at position 55 of NS1. Based on these findings, we produced a PR8/H5N1 reassortant, optimized for this cell line, that derives all of its genes for its internal proteins from the PR8(UW) strain except for the NS gene, which derives from the PR8(Cambridge) strain; its N1 NA gene, which has a long stalk and derives from an early H5N1 strain; and its HA gene, which has an avirulent-type cleavage site sequence and is derived from a circulating H5N1 virus. Our findings demonstrate the importance and feasibility of a cell culture-based approach to producing seed viruses for inactivated H5N1 vaccines that grow robustly and in a timely, cost-efficient manner as an alternative to egg-based vaccine production. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI H5N1 influenza A viruses are exacting a growing human toll, with more than 240 fatal cases to date. In the event of an influenza pandemic caused by these viruses, embryonated chicken eggs, which are the approved substrate for human inactivated-vaccine production, will likely be in short supply because chickens will be killed by these viruses or culled to limit the worldwide spread of the infection. The Madin-Darby canine kidney (MDCK) cell line is a promising alternative candidate substrate because it supports efficient growth of influenza viruses compared to other cell lines. Here, we addressed the molecular determinants for growth of an H5N1 vaccine seed virus in MDCK cells, revealing the critical responsibility of the Tyr residue at position 360 of PB2, the considerable requirement for functional balance between hemagglutinin (HA) and neuraminidase (NA), and the partial responsibility of the Glu residue at position 55 of NS1. Based on these findings, we produced a PR8/H5N1 reassortant, optimized for this cell line, that derives all of its genes for its internal proteins from the PR8(UW) strain except for the NS gene, which derives from the PR8(Cambridge) strain; its N1 NA gene, which has a long stalk and derives from an early H5N1 strain; and its HA gene, which has an avirulent-type cleavage site sequence and is derived from a circulating H5N1 virus. Our findings demonstrate the importance and feasibility of a cell culture-based approach to producing seed viruses for inactivated H5N1 vaccines that grow robustly and in a timely, cost-efficient manner as an alternative to egg-based vaccine production.H5N1 influenza A viruses are exacting a growing human toll, with more than 240 fatal cases to date. In the event of an influenza pandemic caused by these viruses, embryonated chicken eggs, which are the approved substrate for human inactivated-vaccine production, will likely be in short supply because chickens will be killed by these viruses or culled to limit the worldwide spread of the infection. The Madin-Darby canine kidney (MDCK) cell line is a promising alternative candidate substrate because it supports efficient growth of influenza viruses compared to other cell lines. Here, we addressed the molecular determinants for growth of an H5N1 vaccine seed virus in MDCK cells, revealing the critical responsibility of the Tyr residue at position 360 of PB2, the considerable requirement for functional balance between hemagglutinin (HA) and neuraminidase (NA), and the partial responsibility of the Glu residue at position 55 of NS1. Based on these findings, we produced a PR8/H5N1 reassortant, optimized for this cell line, that derives all of its genes for its internal proteins from the PR8(UW) strain except for the NS gene, which derives from the PR8(Cambridge) strain; its N1 NA gene, which has a long stalk and derives from an early H5N1 strain; and its HA gene, which has an avirulent-type cleavage site sequence and is derived from a circulating H5N1 virus. Our findings demonstrate the importance and feasibility of a cell culture-based approach to producing seed viruses for inactivated H5N1 vaccines that grow robustly and in a timely, cost-efficient manner as an alternative to egg-based vaccine production. |
Author | Akira Iwata Kiyoko Iwatsuki-Horimoto Masayuki Shimojima Ayaka Iwasa Yoshihiro Kawaoka Shinya Yamada Shin Murakami Le Quynh Mai Chairul A. Nidom Hualan Chen Taisuke Horimoto Yukiko Muramoto |
AuthorAffiliation | Division of Virology, Department of Microbiology and Immunology, 1 International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2 Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan, 3 National Institute of Hygiene and Epidemiology, Hanoi, Vietnam, 4 Avian Influenza Laboratory, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia, 5 Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China, 6 Nippon Institute for Biological Science, Tokyo, Japan, 7 Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 8 |
AuthorAffiliation_xml | – name: Division of Virology, Department of Microbiology and Immunology, 1 International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2 Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan, 3 National Institute of Hygiene and Epidemiology, Hanoi, Vietnam, 4 Avian Influenza Laboratory, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia, 5 Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China, 6 Nippon Institute for Biological Science, Tokyo, Japan, 7 Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 8 |
Author_xml | – sequence: 1 givenname: Shin surname: Murakami fullname: Murakami, Shin organization: Division of Virology, Department of Microbiology and Immunology – sequence: 2 givenname: Taisuke surname: Horimoto fullname: Horimoto, Taisuke organization: Division of Virology, Department of Microbiology and Immunology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan – sequence: 3 givenname: Le Quynh surname: Mai fullname: Mai, Le Quynh organization: National Institute of Hygiene and Epidemiology, Hanoi, Vietnam – sequence: 4 givenname: Chairul A. surname: Nidom fullname: Nidom, Chairul A. organization: Avian Influenza Laboratory, Tropical Disease Centre, Airlangga University, Surabaya, Indonesia – sequence: 5 givenname: Hualan surname: Chen fullname: Chen, Hualan organization: Animal Influenza Laboratory of the Ministry of Agriculture and National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China – sequence: 6 givenname: Yukiko surname: Muramoto fullname: Muramoto, Yukiko organization: Division of Virology, Department of Microbiology and Immunology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan – sequence: 7 givenname: Shinya surname: Yamada fullname: Yamada, Shinya organization: Division of Virology, Department of Microbiology and Immunology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan – sequence: 8 givenname: Ayaka surname: Iwasa fullname: Iwasa, Ayaka organization: Division of Virology, Department of Microbiology and Immunology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan – sequence: 9 givenname: Kiyoko surname: Iwatsuki-Horimoto fullname: Iwatsuki-Horimoto, Kiyoko organization: Division of Virology, Department of Microbiology and Immunology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan – sequence: 10 givenname: Masayuki surname: Shimojima fullname: Shimojima, Masayuki organization: Division of Virology, Department of Microbiology and Immunology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan – sequence: 11 givenname: Akira surname: Iwata fullname: Iwata, Akira organization: Nippon Institute for Biological Science, Tokyo, Japan – sequence: 12 givenname: Yoshihiro surname: Kawaoka fullname: Kawaoka, Yoshihiro organization: Division of Virology, Department of Microbiology and Immunology, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, Saitama, Japan, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20781169$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18768983$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9vFCEUx4mpsdvqzbMhMfbk1AcDDFxMzLa2q1UP6sYbYYHp0sxAhZk2-tc76671R-LpHfh8v9_3-B6gvZiiR-gxgWNCqHzxZrk4BlANVCDvoRkBJSvOCdtDMwBKK17LL_vooJQrAMKYYA_QPpGNkErWM7Q4y-l2WOMTP_jch2jiUHCbMj7n7wlexLYbffxu8NJYG6LHH713eBnyWHzBIeJ3J_O3eO67rjxE91vTFf9oNw_R59enn-bn1cWHs8X81UVlOYihaqyTjjJbr9S0hXOkMdI4KRRtqFCeG6FaJZywbOVANCtgQIkzhjPWUi5JfYhebn2vx1XvnfVxyKbT1zn0Jn_TyQT990sMa32ZbjTlTU1UPRkc7Qxy-jr6Mug-FDudYKJPY9FCCQlUbZKe_Jl0F_Hr9ybg2Q4wxZquzSbaUO44Co0kRKiJe77lbE6lZN_-tgK9KVFPJeqfJWqQE07_wW0YzBDS5p7Q_U_0dCtah8v1bchem9Lrq5ugJdWUTCIOtP4BNiCpOQ |
CitedBy_id | crossref_primary_10_1016_j_jviromet_2017_08_002 crossref_primary_10_3389_fmicb_2021_693204 crossref_primary_10_1016_j_vaccine_2010_07_076 crossref_primary_10_1128_JVI_02856_12 crossref_primary_10_1586_erv_11_82 crossref_primary_10_2745_dds_24_616 crossref_primary_10_1099_jgv_0_001279 crossref_primary_10_1038_ncomms9148 crossref_primary_10_1637_9315_032410_Reg_1 crossref_primary_10_1016_j_psj_2024_103988 crossref_primary_10_1080_08830185_2018_1500570 crossref_primary_10_1016_j_vaccine_2011_05_069 crossref_primary_10_1099_vir_0_000193 crossref_primary_10_1099_vir_0_020370_0 crossref_primary_10_1128_CMR_00097_12 crossref_primary_10_3390_vaccines10091507 crossref_primary_10_1128_jvi_01840_24 crossref_primary_10_20965_jdr_2014_p0793 crossref_primary_10_1371_journal_pone_0024057 crossref_primary_10_2222_jsv_63_37 crossref_primary_10_1371_journal_pone_0028757 crossref_primary_10_1016_j_jcv_2009_04_010 crossref_primary_10_3390_vaccines8040626 crossref_primary_10_1128_JVI_00076_13 crossref_primary_10_1586_erv_09_128 crossref_primary_10_1016_j_vaccine_2012_03_025 crossref_primary_10_1128_JVI_02069_09 crossref_primary_10_1186_s13567_016_0337_x crossref_primary_10_1016_j_jviromet_2009_09_011 crossref_primary_10_1128_jvi_00776_22 crossref_primary_10_1016_j_psj_2023_102685 crossref_primary_10_1371_journal_ppat_1001106 crossref_primary_10_1016_j_vaccine_2011_08_054 crossref_primary_10_1128_CVI_00024_13 crossref_primary_10_1371_journal_pone_0128982 crossref_primary_10_1186_s12985_016_0585_4 crossref_primary_10_1371_journal_pone_0312776 crossref_primary_10_1186_s12929_020_00645_y crossref_primary_10_1371_journal_pone_0160040 |
Cites_doi | 10.1099/0022-1317-73-5-1159 10.1128/JVI.77.2.1501-1511.2003 10.1128/jvi.67.2.759-764.1993 10.1038/nature02951 10.1128/JVI.76.21.11166-11171.2002 10.1128/JVI.01434-06 10.1128/jvi.67.4.1761-1764.1993 10.1128/JVI.79.11.6763-6771.2005 10.1016/S0264-410X(01)00428-5 10.1128/JVI.79.18.12058-12064.2005 10.1128/jvi.71.4.3357-3362.1997 10.1038/nrmicro1208 10.1073/pnas.85.14.5259 10.1128/JVI.74.24.11566-11573.2000 10.1016/j.vaccine.2005.07.005 10.1016/0042-6822(87)90418-1 10.1073/pnas.94.26.14764 10.1073/pnas.96.16.9345 10.1038/nbt1261 10.1128/JVI.74.13.6015-6020.2000 10.1126/science.1125676 10.1016/j.vaccine.2006.01.019 10.1038/nrmicro979 10.1038/4401099a 10.1371/journal.pmed.0040059 10.1016/0042-6822(85)90332-0 10.1016/S0022-3476(98)70101-5 10.1128/JVI.01876-07 10.1016/j.virol.2007.07.002 10.1056/NEJMoa055778 10.1292/jvms.58.23 10.1016/0042-6822(87)90040-7 |
ContentType | Journal Article |
Copyright | 2008 INIST-CNRS Copyright © 2008, American Society for Microbiology |
Copyright_xml | – notice: 2008 INIST-CNRS – notice: Copyright © 2008, American Society for Microbiology |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1128/JVI.00970-08 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 10509 |
ExternalDocumentID | PMC2573193 18768983 20781169 10_1128_JVI_00970_08 jvi_82_21_10502 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c506t-7cd8d24c3b9187dd17a8ad86927269e5a69f96d6c4bd067b04021daa544f25813 |
ISSN | 0022-538X 1098-5514 |
IngestDate | Thu Aug 21 18:29:54 EDT 2025 Fri Jul 11 12:13:22 EDT 2025 Thu Apr 03 07:02:07 EDT 2025 Mon Jul 21 09:13:03 EDT 2025 Thu Apr 24 23:06:26 EDT 2025 Tue Jul 01 00:57:27 EDT 2025 Wed May 18 15:25:38 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Keywords | Infection Influenzavirus A(H5N1) Seeds Viral disease Influenza Vaccine In vitro Virology |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c506t-7cd8d24c3b9187dd17a8ad86927269e5a69f96d6c4bd067b04021daa544f25813 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Corresponding author. Mailing address: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Phone: 81-3-5449-5281. Fax: 81-3-5449-5408. E-mail for T. Horimoto: horimoto@ims.u-tokyo.ac.jp. E-mail for Y. Kawaoka: kawaoka@ims.u-tokyo.ac.jp |
OpenAccessLink | http://doi.org/10.1128/JVI.00970-08 |
PMID | 18768983 |
PQID | 69680291 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_69680291 pascalfrancis_primary_20781169 crossref_primary_10_1128_JVI_00970_08 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2573193 pubmed_primary_18768983 highwire_asm_jvi_82_21_10502 crossref_citationtrail_10_1128_JVI_00970_08 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-11-01 |
PublicationDateYYYYMMDD | 2008-11-01 |
PublicationDate_xml | – month: 11 year: 2008 text: 2008-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2008 |
Publisher | American Society for Microbiology American Society for Microbiology (ASM) |
Publisher_xml | – name: American Society for Microbiology – name: American Society for Microbiology (ASM) |
References | e_1_3_2_26_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_8_2) 1999; 98 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 (e_1_3_2_27_2) 1995; 1 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 8645752 - J Vet Med Sci. 1996 Jan;58(1):23-7 17651774 - Virology. 2007 Sep 15;366(1):23-7 11090154 - J Virol. 2000 Dec;74(24):11566-73 16472544 - Vaccine. 2006 Apr 12;24(16):3261-72 10494958 - Dev Biol Stand. 1999;98:39-51; discussion 73-4 3134658 - Proc Natl Acad Sci U S A. 1988 Jul;85(14):5259-63 8445709 - J Virol. 1993 Apr;67(4):1761-4 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 17050598 - J Virol. 2007 Jan;81(1):30-41 15378048 - Nat Rev Microbiol. 2004 Oct;2(10):842-7 15890915 - J Virol. 2005 Jun;79(11):6763-71 16571878 - N Engl J Med. 2006 Mar 30;354(13):1343-51 11803087 - Vaccine. 2002 Jan 15;20(7-8):1240-7 16378663 - Vaccine. 2006 Apr 24;24(17):3669-76 18045936 - J Virol. 2008 Feb;82(3):1605-9 9060710 - J Virol. 1997 Apr;71(4):3357-62 9405687 - Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14764-9 15470432 - Nature. 2004 Oct 7;431(7009):703-7 16690858 - Science. 2006 May 12;312(5775):879-82 1588320 - J Gen Virol. 1992 May;73 ( Pt 5):1159-65 16140781 - J Virol. 2005 Sep;79(18):12058-64 10846083 - J Virol. 2000 Jul;74(13):6015-20 4060573 - Virology. 1985 Apr 30;142(2):241-7 12368362 - J Virol. 2002 Nov;76(21):11166-71 8419645 - J Virol. 1993 Feb;67(2):759-64 3629978 - Virology. 1987 Sep;160(1):31-7 8548659 - RNA. 1995 Nov;1(9):948-56 17093488 - Nat Biotechnol. 2006 Nov;24(11):1377-83 9821418 - J Pediatr. 1998 Nov;133(5):624-8 12502864 - J Virol. 2003 Jan;77(2):1501-11 16641963 - Nature. 2006 Apr 27;440(7088):1099 16064053 - Nat Rev Microbiol. 2005 Aug;3(8):591-600 17298168 - PLoS Med. 2007 Feb;4(2):e59 3811239 - Virology. 1987 Feb;156(2):386-95 |
References_xml | – ident: e_1_3_2_17_2 doi: 10.1099/0022-1317-73-5-1159 – ident: e_1_3_2_26_2 doi: 10.1128/JVI.77.2.1501-1511.2003 – ident: e_1_3_2_2_2 doi: 10.1128/jvi.67.2.759-764.1993 – ident: e_1_3_2_18_2 doi: 10.1038/nature02951 – ident: e_1_3_2_21_2 doi: 10.1128/JVI.76.21.11166-11171.2002 – ident: e_1_3_2_25_2 doi: 10.1128/JVI.01434-06 – ident: e_1_3_2_30_2 doi: 10.1128/jvi.67.4.1761-1764.1993 – ident: e_1_3_2_20_2 doi: 10.1128/JVI.79.11.6763-6771.2005 – volume: 98 start-page: 39 year: 1999 ident: e_1_3_2_8_2 publication-title: Dev. Biol. Stand. – ident: e_1_3_2_9_2 doi: 10.1016/S0264-410X(01)00428-5 – ident: e_1_3_2_19_2 doi: 10.1128/JVI.79.18.12058-12064.2005 – ident: e_1_3_2_13_2 doi: 10.1128/jvi.71.4.3357-3362.1997 – ident: e_1_3_2_10_2 doi: 10.1038/nrmicro1208 – ident: e_1_3_2_4_2 doi: 10.1073/pnas.85.14.5259 – ident: e_1_3_2_34_2 doi: 10.1128/JVI.74.24.11566-11573.2000 – ident: e_1_3_2_12_2 doi: 10.1016/j.vaccine.2005.07.005 – ident: e_1_3_2_16_2 doi: 10.1016/0042-6822(87)90418-1 – ident: e_1_3_2_31_2 doi: 10.1073/pnas.94.26.14764 – ident: e_1_3_2_24_2 doi: 10.1073/pnas.96.16.9345 – ident: e_1_3_2_33_2 doi: 10.1038/nbt1261 – ident: e_1_3_2_22_2 doi: 10.1128/JVI.74.13.6015-6020.2000 – ident: e_1_3_2_6_2 doi: 10.1126/science.1125676 – ident: e_1_3_2_7_2 doi: 10.1016/j.vaccine.2006.01.019 – ident: e_1_3_2_35_2 doi: 10.1038/nrmicro979 – ident: e_1_3_2_3_2 doi: 10.1038/4401099a – ident: e_1_3_2_29_2 doi: 10.1371/journal.pmed.0040059 – ident: e_1_3_2_5_2 doi: 10.1016/0042-6822(85)90332-0 – ident: e_1_3_2_15_2 doi: 10.1016/S0022-3476(98)70101-5 – ident: e_1_3_2_23_2 doi: 10.1128/JVI.01876-07 – ident: e_1_3_2_11_2 doi: 10.1016/j.virol.2007.07.002 – ident: e_1_3_2_32_2 doi: 10.1056/NEJMoa055778 – ident: e_1_3_2_14_2 doi: 10.1292/jvms.58.23 – ident: e_1_3_2_28_2 doi: 10.1016/0042-6822(87)90040-7 – volume: 1 start-page: 948 year: 1995 ident: e_1_3_2_27_2 publication-title: RNA – reference: 10494958 - Dev Biol Stand. 1999;98:39-51; discussion 73-4 – reference: 10846083 - J Virol. 2000 Jul;74(13):6015-20 – reference: 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 – reference: 8548659 - RNA. 1995 Nov;1(9):948-56 – reference: 16571878 - N Engl J Med. 2006 Mar 30;354(13):1343-51 – reference: 17093488 - Nat Biotechnol. 2006 Nov;24(11):1377-83 – reference: 9405687 - Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14764-9 – reference: 9821418 - J Pediatr. 1998 Nov;133(5):624-8 – reference: 17651774 - Virology. 2007 Sep 15;366(1):23-7 – reference: 16140781 - J Virol. 2005 Sep;79(18):12058-64 – reference: 16472544 - Vaccine. 2006 Apr 12;24(16):3261-72 – reference: 3811239 - Virology. 1987 Feb;156(2):386-95 – reference: 12502864 - J Virol. 2003 Jan;77(2):1501-11 – reference: 11090154 - J Virol. 2000 Dec;74(24):11566-73 – reference: 12368362 - J Virol. 2002 Nov;76(21):11166-71 – reference: 11803087 - Vaccine. 2002 Jan 15;20(7-8):1240-7 – reference: 18045936 - J Virol. 2008 Feb;82(3):1605-9 – reference: 16690858 - Science. 2006 May 12;312(5775):879-82 – reference: 17298168 - PLoS Med. 2007 Feb;4(2):e59 – reference: 1588320 - J Gen Virol. 1992 May;73 ( Pt 5):1159-65 – reference: 8445709 - J Virol. 1993 Apr;67(4):1761-4 – reference: 16064053 - Nat Rev Microbiol. 2005 Aug;3(8):591-600 – reference: 16641963 - Nature. 2006 Apr 27;440(7088):1099 – reference: 16378663 - Vaccine. 2006 Apr 24;24(17):3669-76 – reference: 3629978 - Virology. 1987 Sep;160(1):31-7 – reference: 15378048 - Nat Rev Microbiol. 2004 Oct;2(10):842-7 – reference: 3134658 - Proc Natl Acad Sci U S A. 1988 Jul;85(14):5259-63 – reference: 4060573 - Virology. 1985 Apr 30;142(2):241-7 – reference: 8645752 - J Vet Med Sci. 1996 Jan;58(1):23-7 – reference: 8419645 - J Virol. 1993 Feb;67(2):759-64 – reference: 15470432 - Nature. 2004 Oct 7;431(7009):703-7 – reference: 9060710 - J Virol. 1997 Apr;71(4):3357-62 – reference: 17050598 - J Virol. 2007 Jan;81(1):30-41 – reference: 15890915 - J Virol. 2005 Jun;79(11):6763-71 |
SSID | ssj0014464 |
Score | 2.1436896 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... H5N1 influenza A viruses are exacting a growing human toll, with more than 240 fatal cases to date. In the event of an influenza pandemic caused by these... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 10502 |
SubjectTerms | Animals Biological and medical sciences Cell Culture Techniques Cell Line Dogs Fundamental and applied biological sciences. Psychology Influenza A Virus, H5N1 Subtype - genetics Influenza A Virus, H5N1 Subtype - growth & development Influenza Vaccines Microbiology Miscellaneous Reassortant Viruses - genetics Reassortant Viruses - growth & development Vaccines and Antiviral Agents Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Viral Plaque Assay Viral Proteins - genetics Viral Proteins - physiology Virology Virus Replication |
Title | Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells |
URI | http://jvi.asm.org/content/82/21/10502.abstract https://www.ncbi.nlm.nih.gov/pubmed/18768983 https://www.proquest.com/docview/69680291 https://pubmed.ncbi.nlm.nih.gov/PMC2573193 |
Volume | 82 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB5FRUhcEDuGUuYAp8jBHo_tmSMKS9KqlRBp1NtovCluEwfFCaj99bw3XuJUqVS4WIkz3vJ9fsu8ZQj5kIpMaEdnNg8cz-aRz2zN49ROJBMgG7UQJlxwehaMzvnxhX_R6_3pVpeso0F8s7eu5H9QhX2AK1bJ_gOy7UlhB3wGfGELCMP2Xhh_Bx96PQOZ0UlpwbTBkX_mwptvlh-50f2pjjF8DnIBrMtpvtqUJgurf_pleNIfpvN5eYeJijVw3Vl3QEVf6YVJAPg5y1tejZYrhNzMuk50Xm6uOhm1Vfl12v-xuS62c895slzU4X64IaDJYGf-QdSFeB2Ziu6sZxYIBo1SiVHsUoq2WFfOCtbhU1UWXUtNsPEc1lHB-F3ul-8MaxaOp-MBFqBgJt5WjzWx-1vqrU06NO4OEwqOVuZohUXiDxj4F8YXH5-04SfwkXnTZh4framYYOJT99q7tkzTXxrTa3UJb1hWLY2yz3e5nYLbsWkmT8jjGmn6uWLWU9JLi2fkYbU86fVzMq74Rbv8osAvivyiLb9ozS-K_KI1v2heUOQXNfx6Qc6_fZ0MR3a99IYd-06wtsM4EQnjsRdJV4RJ4oZa6EQEkoUskKmvA5nJIAliHiVg70SgCpibaO1znjFfuN5LclAsi_Q1oRmXWvoRj0M_41nGIh5I7ok01VniRU5gkX7zJ6q47kuPy6PM1T7ALPKxHf2r6sdyx7jDBg-ly4W6_J0rwRRzlSGbRY52MGrPxbD5lRtIi7xvQFMgcDGKpot0uSkVdpNymHQt8qqCcHsfYFkIKTyLhDvgtgOwlfvuL0U-My3dQXGCLvTe3PPp3pJH21fxkBysV5v0HRjH6-jIEPkvG8q1kQ |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Growth+Determinants+for+H5N1+Influenza+Vaccine+Seed+Viruses+in+MDCK+Cells&rft.jtitle=Journal+of+virology&rft.au=Murakami%2C+Shin&rft.au=Horimoto%2C+Taisuke&rft.au=Mai%2C+Le+Quynh&rft.au=Nidom%2C+Chairul+A.&rft.date=2008-11-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=82&rft.issue=21&rft.spage=10502&rft.epage=10509&rft_id=info:doi/10.1128%2FJVI.00970-08&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_00970_08 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |